# Hereditary Angioedema

This is a subcategory of Respiratory Agents.

## Formulary

### Preferred

| Preferred   | Generic Name | Quantity | Time (Days) |
| :---------- | :----------- | :------: | :---------: |
| Haegarda PA |              |          |             |
| Ruconest PA |              |          |             |
| Takhzyro PA |              |          |             |

### Non-Preferred

| Non-Preferred     | Generic Name | Quantity | Time (Days) |
| :---------------- | :----------- | :------: | :---------: |
| Berinert          |              |          |             |
| Cinryze           |              |          |             |
| Icatibant Acetate |              |          |             |
| Kalbitor          |              |          |             |

## Length of Authorizations

365 Days

**All products in this class require clinical prior authorization**

-   Diagnosis of hereditary angioedema
-   History of recurrent angioedema (without urticaria) within the past 180 days
-   History of recurrent episodes of abdominal pain and vomiting within the past 180 days
-   History of laryngeal edema within the past 180 days
-   Positive family history of angioedema

## Prior Authorization Criteria

Is there any reason the patient cannot be changed to a medication not requiring prior approval? Acceptable reasons include:

-   Allergy to medications not requiring prior approval
-   Contraindication to or drug interaction with medications not requiring prior approval
-   History of unacceptable/toxic side effects to medications not requiring prior approval

## Additional Information

The requested medication may be approved if the following is true:

-   There has been one episode of angioedema during use of a preferred medication

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_Criteria_APPROVED.pdf#page=92)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_APPROVED_.pdf#page=30)
